Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | -9.33% | -18.68% | -29.15% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 3.36M | Sales 2025 * | 9.16M | Capitalization | 78.44M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -83M | EV / Sales 2024 * | 60.6 x |
Net Debt 2024 * | 125M | Net Debt 2025 * | 115M | EV / Sales 2025 * | 21.1 x |
P/E ratio 2024 * |
-0.8
x | P/E ratio 2025 * |
-1.19
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.61% |
Latest transcript on BioXcel Therapeutics, Inc.
1 day | -9.33% | ||
1 week | -18.68% | ||
Current month | -17.06% | ||
1 month | -20.53% | ||
3 months | -0.95% | ||
6 months | -59.57% | ||
Current year | -29.15% |
Managers | Title | Age | Since |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 17-03-28 |
Director of Finance/CFO | 66 | 17-09-30 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 17-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22-06-30 |
Peter Mueller
CHM | Chairman | 68 | 17-03-31 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.09 | -9.33% | 696,007 |
24-05-09 | 2.305 | +8.73% | 665,423 |
24-05-08 | 2.12 | -9.79% | 803,067 |
24-05-07 | 2.35 | -6.37% | 862,502 |
24-05-06 | 2.51 | -2.33% | 377,555 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.15% | 78.44M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BTAI Stock